Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle

Journal of Virology

Volumn 71, Issue 7, 1997, Pages 5115-5123

  Sa Carvalho, Daniel ^a   Rieder, Elizabeth ^a   Baxt, Barry ^a   Rodarte, Renato ^b   Tanuri, Amilcar ^b   Mason, Peter W ^a,c  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ANIMAL CELL; ARTICLE; CATTLE; CELL STRAIN BHK; CHO CELL; CONTROLLED STUDY; FOOT AND MOUTH DISEASE VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN;

EID: 0030971779     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.7.5115-5123.1997     Document Type: Article

References (45)

1. Acharya, R., E. Fry, D. Stuart, G. Fox, D. Rowlands, and F. Brown. 1989. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337:709-716.
2. Alonso, A., G. C. Darsie, A. C. Teixeira, J. L. Reis, and J. A. Mesquita. 1994. Application of monoclonal antibodies to quality control of foot-and-mouth disease vaccines. Vaccine 12:682-696.
3. Baxt, B., and Y. Becker. 1990. The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 4:73-83.
4. Baxt, B., and P. W. Mason. 1995. Foot-and-mouth disease virus undergoes restricted replication in macrophage cell cultures following Fc receptor-mediated adsorption. Virology 207:503-509.
5. 1 involved in neutralization and cell attachment. J. Virol. 51:298-305.
6. Bergelson, J. M., M. P. Shepley, B. M. C. Chan, M. E. Hemler, and R. W. Finberg. 1992. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255:1718-1720.
7. 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J. Virol. 69:2664-2666.
8. Bolwell, C., A. L. Brown, P. V. Barnett, R. O. Campbell, B. E. Clarke, N. R. Parry, E. J. Ouldridge, F. Brown, and D. J. Rowlands. 1989. Host cell selection of antigenic variants of foot-and-mouth disease virus. J. Gen. Virol. 70:45-57.
9. 8a. Brown, F. Personal communication.
10. Chang, K. H., P. Auvinen, T. Hyypiä, and G. Stanway. 1989. The nucleotide sequence of coxsackievirus A9; implications for receptor binding and entero-virus classification. J. Gen. Virol. 70:3269-3280.
11. Forss, S., K. Strebel, E. Beck, and H. Schaller. 1984. Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res. 12:6587-6601.
12. Fox, G., N. R. Parry, P. V. Barnett, B. McGinn, D. Rowlands, and F. Brown. 1989. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J. Gen. Virol. 70:625-637.
13. Fry, E., D. Logan, R. Acharya, G. Fox, D. Rowlands, F. Brown, and D. Stuart. 1990. Architecture and topography of an aphthovirus. Semin. Virol. 1:439-451.
14. Gebauer, F., J. C. de la Torre, I. Gomes, M. G. Mateu, H. Barahona, B. Tiraboschi, I. Bergmann, P. Augé de Mello, and E. Domingo. 1988. Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle. J. Virol. 62:2041-2049.
15. Hughes, P. J., C. Horsnell, T. Hyypiä, and G. Stanway. 1995. The coxsackievirus A9 RGD motif is not essential for virus viability. J. Virol. 69:8035-8040.
16. Jackson, T., F. M. Ellard, R. Abu Ghazaleh, S. M. Brookes, W. E. Blakemore, A. H. Corteyn, D. I. Stuart, J. W. I. Newman, and A. M. Q. King. 1996. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 70:5282-5287.
17. 1 Campos. Virology 193:604-613.
18. Kitson, J. D. A., D. McCahon, and G. J. Belsham. 1990. Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179:26-34.
19. Lea, S., R. Abu-Ghazaleh, W. Blakemore, S. Curry, E. Fry, T. Jackson, A. King, D. Logan, J. Newman, and D. Stuart. 1995. Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67. Structure 3:571-580.
20. Lea, S., J. Hernández, W. Blakemore, E. Brocchi, S. Corry, E. Domingo, E. Fry, R. Abu-Ghazaleh, A. King, J. Newman, D. Stuart, and M. G. Mateu. 1994. The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2:123-139.
21. Logan, D., R. Abu-Ghazaleh, W. Blakemore, S. Curry, T. Jackson, A. King, S. Lea, R. Lewis, J. Newman, N. Parry, D. Rowlands, D. Stuart, and E. Fry. 1993. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362:566-568.
22. Marquardt, O., K.-H. Adam, and O. C. Straub. 1991. Detection and localization of single-base sequence differences in foot-and-mouth disease virus genomes by the RNase mismatch cleavage method. J. Virol. Methods 33: 267-282.
23. Mason, P. W., B. Baxt, F. Brown, J. Harber, A. Murdin, and E. Wimmer. 1993. Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect cells via the Fc receptor. Virology 192:568-577.
24. Mason, P. W., E. Rieder, and B. Baxt. 1994. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. USA 91:1932-1936.
25. Mateu, M. G. 1995. Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res. 38:1-24.
26. Mateu, M. G., J. Hernández, M. A. Martínez, D. Feigelstock, S. Lea, J. J. Pérez, E. Giralt, D. Stuart, E. L. Palma, and E. Domingo. 1994. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J. Virol. 68:1407-1417.
27. Mateu, M. G., M. A. Martínez, E. Rocha, D. Andren, J. Parejo, E. Giralt, F. Sobrino, and E. Domingo. 1989. Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc. Natl. Acad. Sci. USA 86:5883-5887.
28. McKenna, T. S. C., J. Lubroth, E. Rieder, B. Baxt, and P. W. Mason. 1995. Receptor binding-site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J. Virol. 69:5787-5790.
29. Meyer, R. F., M. Pacciarini, E. J. Hilyard, S. Ferrari, V. N. Vakharia, G. Donini, E. Brocchi, and T. W. Molitor. 1994. Genetic variation of foot-and-mouth disease virus from field outbreaks to laboratory isolation. Virus Res. 32:299-312.
30. Patel, M., M. Yanagishita, G. Roderiquez, D. C. Bouhabib, T. Oravecz, V. C. Hascall, and M. A. Norcross. 1993. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Hum. Retroviruses 9:167-174.
31. Pfaff, E., H.-J. Thiel, E. Beck, K. Strohmaier, and H. Schaller. 1988. Analysis of neutralizing epitopes on foot-and-mouth disease virus. J. Virol. 62:2033-2040.
32. 12 have low affinity for cells in culture. J. Virol. 68:5296-5299.
33. Rieder, E., B. Baxt, J. Lubroth, and P. W. Mason. 1994. Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV. J. Virol. 68:7092-7098.
34. Rieder, E., A. Berinstein, B. Baxt, A. Kang, and P. W. Mason. 1996. Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus. Proc. Natl. Acad. Sci. USA 93:10428-10433.
35. Rieder, E., T. Bunch, F. Brown, and P. W. Mason. 1993. Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 67:5139-5145.
36. 3 integrin, the vitronectin receptor. Virology 203:357-365.
37. Roivainen, M., T. Hyypiä, L. Piirainen, N. Kalkkinen, G. Stanway, and T. Hovi. 1991. RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J. Virol. 65: 4735-4740.
38. Rueckert, R. R., and E. Wimmer. 1984. Systematic nomenclature of picornavirus proteins. J. Virol. 50:957-959.
39. Saiki, R. K., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
40. Smith, T. J. 1995. MolView: a program for analyzing and displaying atomic structures on the Macintosh personal computer. J. Mol. Graphics 13:122-125.
41. Sobrino, F., M. Dávila, J. Ortín, and E. Domingo. 1983. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128:310-318.
42. Spear, P. G. 1993. Entry of alphaherpesviruses into cells. Semin. Virol. 4:167-180.
43. Stave, J. W., J. L. Card, D. O. Morgan, and V. N. Vakharia. 1988. Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants. Virology 162:21-29.
44. Stuart, D. Personal communication.
45. WuDunn, D., and P. G. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58.